Chinese pharmaceutical companies, once known mainly for producing cheap generic medicines, are now developing original obesity and weight-loss drugs aimed at competing with Western blockbusters like Ozempic and Wegovy. Several firms are advancing candidates through clinical trials and striking licensing deals with major international drugmakers.
wsj.com
· 2026-09-11
Fast Company released its Best Workplaces for Innovators 2026 list for the biotech, healthcare, and life sciences category, naming 10 companies as top honorees. Five of those winning companies are based in the Boston area, underscoring the region's concentration of biotech talent and innovation.
fastcompany.com
· 2026-09-08
Vijay Pande, who built Andreessen Horowitz's biotech investing practice into a nearly $4 billion operation, has departed to co-found a much smaller firm called VZVC with longtime investor Zach Werner. The new fund makes only a handful of concentrated investments each year instead of dozens, forgoes associates, and leans heavily on AI tools to run its operations.
techcrunch.com
· 2026-08-29